ZNF334, a newly identified member of ZNFs, was initially identified as a molecular marker involved in rheumatoid arthritis (RA) and was extremely reduced in CD4 lymphocytes of RA [25, 26]. Here, CD4 is linked to rheumatoid arthritis.